Bactrocin

For external use only. Apply a thin layer of ointment to the affected skin area after thoroughly cleaning it. Gently rub it in. Wash hands before and after application.

Mupirocin inhibits bacterial protein synthesis by reversibly binding to bacterial isoleucyl-tRNA synthetase, an enzyme crucial for the incorporation of isoleucine into bacterial proteins.

• Hypersensitivity to mupirocin or any of the excipients.
• Not for ophthalmic or intranasal use (unless specifically Bactrocin Nasal Ointment).
• Avoid use on large open wounds or burns due to potential for increased systemic absorption.

Store below 25°C in a dry place, away from direct light. Do not freeze. Keep out of reach of children.

Accidental ingestion of Bactrocin Ointment is unlikely to cause systemic toxicity due to poor systemic absorption. Topical overdose is unlikely to cause systemic effects but may lead to local irritation. In case of accidental ingestion, symptomatic and supportive treatment should be given.

Pregnancy Category B. Limited data from human pregnancies indicate no increased risk of major birth defects or miscarriage with mupirocin. Use during pregnancy only if clearly needed. It is unknown if mupirocin is excreted in human milk, but due to minimal systemic absorption, adverse effects on breastfed infants are unlikely. Use with caution during lactation.

• Hypersensitivity to mupirocin or any of the excipients.
• Not for ophthalmic or intranasal use (unless specifically Bactrocin Nasal Ointment).
• Avoid use on large open wounds or burns due to potential for increased systemic absorption.

Store below 25°C in a dry place, away from direct light. Do not freeze. Keep out of reach of children.

Accidental ingestion of Bactrocin Ointment is unlikely to cause systemic toxicity due to poor systemic absorption. Topical overdose is unlikely to cause systemic effects but may lead to local irritation. In case of accidental ingestion, symptomatic and supportive treatment should be given.

Pregnancy Category B. Limited data from human pregnancies indicate no increased risk of major birth defects or miscarriage with mupirocin. Use during pregnancy only if clearly needed. It is unknown if mupirocin is excreted in human milk, but due to minimal systemic absorption, adverse effects on breastfed infants are unlikely. Use with caution during lactation.